The interaction of MAVS with cytosolic phospholipase A2 (cPLA2) promotes a proinflammatory transcriptional program associated with pathogenesis in neurologic diseases such as experimental autoimmune encephalomyelitis and multiple sclerosis (70). Here, PLA2G4A is linked to experimental autoimmune encephalomyelitis.